Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, approved for the treatment of Parkinson's disease. While this medication effectively improves motor symptoms, a series of potential side effect risks are associated with its efficacy.
What Are the Side Effects of Rasagiline (Azilect)?
Common Reactions in Monotherapy
Influenza-like symptoms (5%).
Arthralgia (7%).
Dyspepsia (7%).
Depression (5%).
Headache (14%).
Falls (5%).
Side Effects in Adjunctive Therapy Without Levodopa
Peripheral edema (7%).
Falls (6%).
Cough (4%).
Side Effects in Adjunctive Therapy With Levodopa
Dyskinesia (18%).
Accidental injuries (12%).
Weight loss (9%).
Warnings for Severe Side Effects of Rasagiline (Azilect).
Risk of Hypertension
May exacerbate hypertension; new-onset hypertension or poorly controlled blood pressure should be monitored.
When used in combination with levodopa, the incidence of significant blood pressure elevation (systolic blood pressure > 180 mmHg or diastolic blood pressure > 100 mmHg) is 4%.
Although routine dietary tyramine restriction is not required, consumption of foods containing extremely high amounts of tyramine (> 150 mg) should be avoided.
Serotonin Syndrome
High-risk contraindicated concomitant medications: meperidine, tramadol, methadone, dextromethorphan.
Other MAO inhibitors (including selective MAO-B inhibitors).
St. John's wort, cyclobenzaprine.
Other Severe Neurological Reactions
Dyskinesia.
Hallucinations/psychotic-like behaviors.
Impulse control/compulsive behaviors.
Withdrawal-related hyperpyrexia and confusion.
Precautions for Using Rasagiline (Azilect)
Individualized Dosing Regimen
Monotherapy: 1 mg once daily.
Adjunctive therapy without levodopa: 1 mg once daily.
Adjunctive therapy with levodopa: Initial dose of 0.5 mg once daily, which may be increased to 1 mg once daily.
Dosage Adjustments for Special Populations
Patients taking ciprofloxacin or other CYP1A2 inhibitors: Do not exceed 0.5 mg once daily.
Mild hepatic impairment: Do not exceed 0.5 mg once daily.
Moderate or severe hepatic impairment: Contraindicated.
Lifestyle Management
Driving warning: Avoid driving if somnolence occurs.
Dietary advice: Avoid large amounts of tyramine-containing foods (e.g., aged cheese).
Symptom Reporting Mechanism
Recognize symptoms of hepatotoxicity: unusual fatigue, abdominal pain, jaundice.
Report new or worsening psychiatric symptoms: hallucinations, abnormal impulses, etc.
